ROBERT BROWN: Open Payments
NPI 1649051962 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 65 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $132 · 2025 $1,290
Food & beverage: $1,235Education: $55
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 30 | $380 |
| AstraZeneca Pharmaceuticals LP | 10 | $300 |
| Actelion Pharmaceuticals US, Inc. | 3 | $136 |
| GENZYME CORPORATION | 4 | $94 |
| HARMONY BIOSCIENCES LLC | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Viatris Specialty LLC | 3 | $56 |
| Insmed, Inc. | 2 | $43 |
| Grifols USA, LLC | 1 | $27 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, DUPIXENT, NUCALA, UPTRAVI, BREZTRI, WINREVAIR, YUPELRI.
Industry payments across TX — which companies pay providers there.
